A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome.
Kidney Int
; 97(6): 1275-1286, 2020 06.
Article
em En
| MEDLINE
| ID: mdl-32299679
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Ramipril
/
Nefrite Hereditária
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Child
/
Humans
Idioma:
En
Revista:
Kidney Int
Ano de publicação:
2020
Tipo de documento:
Article